Trial intelligence / Profile preview

Sotrastaurin + Tacrolimus in de Novo Liver Transplant

NCT01128335Phase 2Completed

Sponsor
Novartis
Start
Apr 2010
Primary completion
Jul 2012
Modality
Small Molecules
Countries
12
01

Overview

A Phase 2 trial of sotrastaurin in Liver transplant rejection, sponsored by Novartis. Started Apr 2010; status: completed.

02

Drugs

sotrastaurin
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT01128335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01128335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call